busulfan has been researched along with Inflammation in 9 studies
Inflammation: A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The purpose of this study was to evaluate the toxicity and efficacy of high-dose busulfan, melphalan and thiotepa (Bu/Mel/TT) in patients with high-risk non-inflammatory breast cancer defined as stage II disease > or =10 lymph nodes (n = 52) or stage III (n = 69), and prognostic factors for treatment outcome." | 9.09 | High-dose busulfan, melphalan and thiotepa as consolidation for non-inflammatory high-risk breast cancer. ( Appelbaum, FR; Bensinger, W; Gutierrez-Delgado, F; Holmberg, LA; Hooper, H; Kawahara, K; Livingston, RB; Maziarz, RT; Montgomery, P; Rivkin, S; Weiden, P, 2000) |
| "The purpose of this study was to evaluate the toxicity and efficacy of high-dose busulfan, melphalan and thiotepa (Bu/Mel/TT) in patients with high-risk non-inflammatory breast cancer defined as stage II disease > or =10 lymph nodes (n = 52) or stage III (n = 69), and prognostic factors for treatment outcome." | 5.09 | High-dose busulfan, melphalan and thiotepa as consolidation for non-inflammatory high-risk breast cancer. ( Appelbaum, FR; Bensinger, W; Gutierrez-Delgado, F; Holmberg, LA; Hooper, H; Kawahara, K; Livingston, RB; Maziarz, RT; Montgomery, P; Rivkin, S; Weiden, P, 2000) |
| " Our aim was to compare non-myeloablative busulfan conditioning against head-shielded irradiation bone marrow chimeras prior to implantation of glioblastoma, a malignant brain tumour with a pro-inflammatory phenotype." | 3.91 | Non-myeloablative busulfan chimeric mouse models are less pro-inflammatory than head-shielded irradiation for studying immune cell interactions in brain tumours. ( Bigger, BW; Forte, G; Kamaly-Asl, ID; Liao, A; O'Leary, C; Parker, H; Rowlston, S; Telfer, B; Williams, K; Youshani, AS, 2019) |
| "Exacerbation of infection during aplasia was observed in 3 patients; inflammatory flare at the infection site during neutrophil engraftment in 2: all 5 patients belonged to the subgroup of 9 with pre-existing infection." | 2.41 | Treatment of chronic granulomatous disease with myeloablative conditioning and an unmodified hemopoietic allograft: a survey of the European experience, 1985-2000. ( Belohradsky, BH; Blanche, S; Bordigoni, P; Cant, A; Di Bartolomeo, P; Fischer, A; Flood, T; Gungor, T; Landais, P; Müller, S; Nagler, A; Ozsahin, H; Passwell, JH; Porta, F; Seger, RA; Slavin, S; Wulffraat, N; Zintl, F, 2002) |
| "Busulfan (BUS) is an anticancer agent with serious adverse effects on various body organs, including the lung and testis." | 1.91 | Sitagliptin ameliorates busulfan-induced pulmonary and testicular injury in rats through antioxidant, anti-inflammatory, antifibrotic, and antiapoptotic effects. ( Abbas, MA; Ali, EA; Tayel, SG, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (22.22) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Saunders, MJ | 1 |
| Edwards, BS | 1 |
| Zhu, J | 1 |
| Sklar, LA | 1 |
| Graves, SW | 1 |
| Ali, EA | 1 |
| Tayel, SG | 1 |
| Abbas, MA | 1 |
| Skurikhin, EG | 1 |
| Pakhomova, AV | 1 |
| Pershina, OV | 1 |
| Ermolaeva, LA | 1 |
| Krupin, VA | 1 |
| Ermakova, NN | 1 |
| Pan, ES | 1 |
| Kudryashova, AI | 1 |
| Rybalkina, OY | 1 |
| Pavlovskaya, TB | 1 |
| Litvyakov, NV | 1 |
| Goldberg, VE | 1 |
| Dygai, AM | 1 |
| Youshani, AS | 1 |
| Rowlston, S | 1 |
| O'Leary, C | 1 |
| Forte, G | 1 |
| Parker, H | 1 |
| Liao, A | 1 |
| Telfer, B | 1 |
| Williams, K | 1 |
| Kamaly-Asl, ID | 1 |
| Bigger, BW | 1 |
| Qiao, J | 1 |
| Huang, Y | 1 |
| Xia, Y | 1 |
| Chu, P | 1 |
| Yao, H | 1 |
| Xu, L | 1 |
| Qi, K | 1 |
| Liu, Y | 1 |
| Xu, K | 1 |
| Zeng, L | 1 |
| Seger, RA | 1 |
| Gungor, T | 1 |
| Belohradsky, BH | 1 |
| Blanche, S | 1 |
| Bordigoni, P | 1 |
| Di Bartolomeo, P | 1 |
| Flood, T | 1 |
| Landais, P | 1 |
| Müller, S | 1 |
| Ozsahin, H | 1 |
| Passwell, JH | 1 |
| Porta, F | 1 |
| Slavin, S | 1 |
| Wulffraat, N | 1 |
| Zintl, F | 1 |
| Nagler, A | 1 |
| Cant, A | 1 |
| Fischer, A | 1 |
| WEBER, RE | 1 |
| HELMAN, N | 1 |
| Gutierrez-Delgado, F | 1 |
| Holmberg, LA | 1 |
| Hooper, H | 1 |
| Appelbaum, FR | 1 |
| Livingston, RB | 1 |
| Maziarz, RT | 1 |
| Weiden, P | 1 |
| Rivkin, S | 1 |
| Montgomery, P | 1 |
| Kawahara, K | 1 |
| Bensinger, W | 1 |
| Dukes, M | 1 |
| Chan, WC | 1 |
| Willoughby, DA | 1 |
1 review available for busulfan and Inflammation
| Article | Year |
|---|---|
Treatment of chronic granulomatous disease with myeloablative conditioning and an unmodified hemopoietic allograft: a survey of the European experience, 1985-2000.
Topics: Adolescent; Adult; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodie | 2002 |
1 trial available for busulfan and Inflammation
| Article | Year |
|---|---|
High-dose busulfan, melphalan and thiotepa as consolidation for non-inflammatory high-risk breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Busulfan; Chemotherapy, Adj | 2000 |
7 other studies available for busulfan and Inflammation
| Article | Year |
|---|---|
Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
Topics: Animals; Biotinylation; Flow Cytometry; Fluorescence Resonance Energy Transfer; Green Fluorescent Pr | 2010 |
Sitagliptin ameliorates busulfan-induced pulmonary and testicular injury in rats through antioxidant, anti-inflammatory, antifibrotic, and antiapoptotic effects.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Apoptosis; Busulfan; Caspase 3; Humans; Inflammatio | 2023 |
Regenerative Potential of Spermatogonial Stem Cells, Endothelial Progenitor Cells, and Epithelial Progenitor Cells of C57Bl/6 Male Mice with Metabolic Disorders.
Topics: Animals; Busulfan; CD24 Antigen; CD52 Antigen; Endothelial Progenitor Cells; Inflammation; Integrin | 2017 |
Non-myeloablative busulfan chimeric mouse models are less pro-inflammatory than head-shielded irradiation for studying immune cell interactions in brain tumours.
Topics: Animals; Antineoplastic Agents, Alkylating; Bone Marrow Cells; Brain Neoplasms; Busulfan; Cell Line, | 2019 |
Busulfan and cyclosphamide induce liver inflammation through NLRP3 activation in mice after hematopoietic stem cell transplantation.
Topics: Adenosine Triphosphate; Animals; Busulfan; Carrier Proteins; Chemical and Drug Induced Liver Injury; | 2015 |
THE LOCAL INFLAMMATORY RESPONSE IN PATIENTS WITH BLOOD DYSCRASIAS AS TESTED BY THE SKIN WINDOW TECHNIQUE.
Topics: Busulfan; Hodgkin Disease; Inflammation; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid; Leukocyte | 1963 |
The effect of various immunosuppressive agents on the vascular and cellular response to carvageenan in the rat.
Topics: Animals; Azathioprine; Busulfan; Carrageenan; Chlorambucil; Cyclophosphamide; Edema; Immunosuppressi | 1973 |